The pooled HRs of analysis of among women with either HER-2 positive or HER-2 negative status showed a favorable trend but no statistical difference between the 2 treatment arms.
← all excerpts
Adjuvant chemotherapy, with or without taxanes, in early or operable breast cancer: a meta-analysis of 19 randomized trials with 30698 patients.
1
—
—